entertainment -WSS

entertainment

author：explore 2025-10-01 21:35:01 - browse：383

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： As health system earnings go up, health insurance stocks go down

WSS

How a small hospital in rural Puerto Rico survived Hurricane Maria

Brain technologies pose threats that are all too real, experts warn

Primary care doctor shortage won't be solved by free med school tuition

GSK’s asthma push continues as drug succeeds in Phase 3 trials

BIO to announce reorganization, senior leaders expected to depart

Has Bernie Sanders reached the limit of his pharma bullying effort?

explore

entertainment

focus

Supreme Court strikes down use of affirmative action

AI for drug discovery: Experts on separating hype from reality

Cancer drug shortages should be causing more outrage

Empower primary care with adequate payments and technology

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The creative science of coining drug names

United colonoscopy coverage change 'may cost lives,' doctors say

Most antidepressants don't work on kids, teens, study finds

In age of alternative facts, a scholarly course on calling out crap

Deliver public health messages at the right time

hotspot

Warren pushes Witty on UnitedHealth's control over physicians

Chemotherapy before breast cancer surgery might fuel metastasis

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Most antidepressants don't work on kids, teens, study finds

Can gargling with Listerine treat gonorrhea of the mouth?

PBM executives asked to testify by House panel

explore

Wikipedia

Wikipedia

leisure time